VP-GSTN by Virtus Pharmaceuticals VP-GSTN

VP-GSTN by

Drug Labeling and Warnings

VP-GSTN by is a Other medication manufactured, distributed, or labeled by Virtus Pharmaceuticals. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

VP-GSTN- cholecalciferol, genistein, and zinc glycinate citrate capsule 
Virtus Pharmaceuticals

----------

VP-GSTN

Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving% Daily Value
  • * Daily Value not established
  • Equivalent to 4 mg elemental zinc.
  • Vitamin D (Vitamin D3 as cholecalciferol)

    200 IU

    50%

    Genistein Aglycone

    27 mg

    *

    Citrated Zinc Bisglycinate Chelate

    20 mg

    *

    Other Ingredients: Microcrystalline Cellulose, Capsule (Gelatin, Purified Water, and Titanium Dioxide) with Black Ink (Shellac, Black Iron Oxide, Propylene Glycol), Magnesium Stearate, Fumed Silica, Magnesium Oxide, Dicalcium Malate.

    Contains Soy

    DESCRIPTION

    VP-GSTN is an orally administered prescription dietary supplement for the support of bone health and should be administered under the supervision of a licensed medical practitioner.

    DOSAGE AND ADMINISTRATION

    One capsule twice daily, approximately 12 hours apart, or as directed by a licensed healthcare practitioner. VP-GSTN may be taken with or without food. If gastrointestinal upset occurs, taking VP-GSTN with food may reduce or eliminate these symptoms. There are no postural limitations.

    VP-GSTN is contraindicated in pregnant and/or lactating women as well as patients with a history of cancer of the breast and/or reproductive organs.

    Store at 15° – 30°C (59° – 86°F). [See USP Controlled Room Temperature.] Protect from light and moisture. Dispense in a tight, light-resistant container. Notice: Contact with moisture may produce surface discoloration or erosion.

    Call your licensed medical practitioner about side effects. You may report side effects by calling 1-888-848-3593 or FDA at 1-800-FDA-1088.

    HOW SUPPLIED

    Supplied as oblong, white-colored capsule imprinted "V222" dispensed in bottles of 60 capsules.

    Manufactured for:
    Virtus Pharmaceuticals, LLC
    Tampa, Florida 33619
    1-888-848-3593

    Made in Canada

    Rev. 02/15

    PRINCIPAL DISPLAY PANEL - 60 Capsule Bottle Label

    VIRTUS
    PHARMACEUTICALS
    69543-222-60

    VP-GSTN
    Prescription Dietary Supplement
    containing Genistein Aglycone,
    Citrated Zinc Bisglycinate,
    and Cholecalciferol

    Rx
    60 Capsules

    Principal Display Panel - 60 Capsule Bottle Label
    VP-GSTN 
    cholecalciferol, genistein, and zinc glycinate citrate capsule
    Product Information
    Product TypeDIETARY SUPPLEMENTItem Code (Source)NHRIC:69543-222
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL200 [iU]
    GENISTEIN (UNII: DH2M523P0H) (GENISTEIN - UNII:DH2M523P0H) GENISTEIN27 mg
    ZINC GLYCINATE CITRATE (UNII: H3472PJ7YA) (ZINC CATION - UNII:13S1S8SF37) ZINC GLYCINATE CITRATE20 mg
    Inactive Ingredients
    Ingredient NameStrength
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    GELATIN, UNSPECIFIED (UNII: 2G86QN327L)  
    WATER (UNII: 059QF0KO0R)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    SHELLAC (UNII: 46N107B71O)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MAGNESIUM OXIDE (UNII: 3A3U0GI71G)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NHRIC:69543-222-6060 in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Dietary Supplement12/04/201511/30/2019
    Supplement Facts
    Serving Size : Serving per Container :
    Amount Per Serving% Daily Value
    color
    size (solid drugs)15 mm
    shape
    scoring1
    imprint
    Labeler - Virtus Pharmaceuticals (079659493)

    Revised: 12/2019
     

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.